2E,6E-farnesol

2e,6e-farnesol is a lipid of Prenol Lipids (PR) class. 2e,6e-farnesol is associated with abnormalities such as Granulomatous Disease, Chronic, pathologic fistula and Cavitation. The involved functions are known as Regulation, Metabolic Inhibition, cholesterol biosynthetic process, Process and Transcription, Genetic. 2e,6e-farnesol often locates in Plasma membrane, Cytoplasmic matrix, cornified envelope, Epidermis and peroxisome. The associated genes with 2E,6E-farnesol are RAB3A gene, FOSL1 gene, CASP8AP2 gene, RCC1 gene and GALE gene. The related lipids are Sterols, Membrane Lipids and Steroids.

Cross Reference

Introduction

To understand associated biological information of 2E,6E-farnesol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2E,6E-farnesol?

2E,6E-farnesol is suspected in Granulomatous Disease, Chronic, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2E,6E-farnesol

MeSH term MeSH ID Detail
Leukemia, Myeloid D007951 52 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Dermatomycoses D003881 17 associated lipids
Hypergammaglobulinemia D006942 9 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Meningioma D008579 11 associated lipids
Neuritis, Autoimmune, Experimental D009444 4 associated lipids
Glioblastoma D005909 27 associated lipids
Nephritis D009393 19 associated lipids
Per page 10 20 50 | Total 42

PubChem Associated disorders and diseases

What pathways are associated with 2E,6E-farnesol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2E,6E-farnesol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2E,6E-farnesol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2E,6E-farnesol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2E,6E-farnesol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 2E,6E-farnesol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2E,6E-farnesol

Download all related citations
Per page 10 20 50 100 | Total 950
Authors Title Published Journal PubMed Link
Zhao Y et al. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells. 2016 Eur. J. Cancer pmid:27710830
pmid:27665610
pmid:27623739
Seman-Kamarulzaman AF et al. Novel NAD+-Farnesal Dehydrogenase from Polygonum minus Leaves. Purification and Characterization of Enzyme in Juvenile Hormone III Biosynthetic Pathway in Plant. 2016 PLoS ONE pmid:27560927
pmid:27440491
Sun J et al. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel. 2016 Acta Biomater pmid:27422196
Bandara HM et al. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro. 2016 Mol. Pharm. pmid:27383205
pmid:27357648
Mohamed MA et al. Polyacrylamide gel miniaturization improves protein visualization and autoradiographic detection. 1989 Anal. Biochem. pmid:2729547
pmid:27239017
Inoue Y et al. Farnesol-Induced Disruption of the Staphylococcus aureus Cytoplasmic Membrane. 2016 Biol. Pharm. Bull. pmid:27150138
pmid:27138105
Léger T et al. The Metacaspase (Mca1p) Restricts O-glycosylation During Farnesol-induced Apoptosis in Candida albicans. 2016 Mol. Cell Proteomics pmid:27125826
pmid:27021020
pmid:26992462
pmid:26972663
pmid:26968084
Zhu J et al. Mevalonate-Farnesal Biosynthesis in Ticks: Comparative Synganglion Transcriptomics and a New Perspective. 2016 PLoS ONE pmid:26959814
pmid:26923572
pmid:26905659
Lemaire B et al. Cytochrome P450 20A1 in zebrafish: Cloning, regulation and potential involvement in hyperactivity disorders. 2016 Toxicol. Appl. Pharmacol. pmid:26853319
Cheng HL et al. Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways. 2016 Oncotarget pmid:26848867
Jung SI et al. Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades. 2016 PLoS ONE pmid:26848577
Abdel-Rhman SH et al. Effect of Tyrosol and Farnesol on Virulence and Antibiotic Resistance of Clinical Isolates of Pseudomonas aeruginosa. 2015 Biomed Res Int pmid:26844228
Casey PJ et al. p21ras is modified by a farnesyl isoprenoid. 1989 Proc. Natl. Acad. Sci. U.S.A. pmid:2682646
Lowy DR and Willumsen BM Protein modification: new clue to Ras lipid glue. 1989 Nature pmid:2677741
Agnew WS and Popják G Squalene synthetase. Stoichiometry and kinetics of presqualene pyrophosphate and squalene synthesis by yeast microsomes. 1978 J. Biol. Chem. pmid:26684
pmid:26669506
Torabi S and Mo H Trans, trans-farnesol as a mevalonate-derived inducer of murine 3T3-F442A pre-adipocyte differentiation. 2016 Exp. Biol. Med. (Maywood) pmid:26660152
pmid:26626450
pmid:26546815
Kostoulias X et al. Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology. 2015 Antimicrob. Agents Chemother. pmid:26482299
pmid:26442918
Hameiri-Grossman M et al. The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth. 2015 Oncotarget pmid:26393682
pmid:26365385
pmid:26341906
Strube-Bloss MF et al. Extracting the Behaviorally Relevant Stimulus: Unique Neural Representation of Farnesol, a Component of the Recruitment Pheromone of Bombus terrestris. 2015 PLoS ONE pmid:26340263
pmid:26318416
Lopez-Medina E et al. Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis. 2015 PLoS Pathog. pmid:26313907
Joo JH et al. Farnesol activates the intrinsic pathway of apoptosis and the ATF4-ATF3-CHOP cascade of ER stress in human T lymphoblastic leukemia Molt4 cells. 2015 Biochem. Pharmacol. pmid:26275811
Krause J et al. Prostaglandin E2 from Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms. 2015 PLoS ONE pmid:26262843
Mogen AB et al. Pluronics-Formulated Farnesol Promotes Efficient Killing and Demonstrates Novel Interactions with Streptococcus mutans Biofilms. 2015 PLoS ONE pmid:26222384
pmid:26198568
Hargarten JC et al. Candida albicans Quorum Sensing Molecules Stimulate Mouse Macrophage Migration. 2015 Infect. Immun. pmid:26195556
pmid:26162644
Ershova LS et al. [The action of a juvenile hormone synthetic analog--ether-farnesol on Xenopsylla cheopis fleas]. 1989 Sep-Oct Parazitologia pmid:2616197
pmid:26143865
Supuran CT Nanoparticles for controlled release of anti-biofilm agents WO2014130994 (A1): a patent evaluation. 2015 Expert Opin Ther Pat pmid:26028186
pmid:25976810
Stoddart CA et al. Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque. 2015 Antimicrob. Agents Chemother. pmid:25941222